These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 35911994)

  • 1. Implications of Diabetes-Induced Altered Metabolites on Retinal Neurodegeneration.
    Aldosari DI; Malik A; Alhomida AS; Ola MS
    Front Neurosci; 2022; 16():938029. PubMed ID: 35911994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodegeneration and neuroprotection in diabetic retinopathy.
    Ola MS; Nawaz MI; Khan HA; Alhomida AS
    Int J Mol Sci; 2013 Jan; 14(2):2559-72. PubMed ID: 23358247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal Cell Damage in Diabetic Retinopathy.
    Zhou J; Chen B
    Cells; 2023 May; 12(9):. PubMed ID: 37174742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal Neurodegeneration in Diabetes: an Emerging Concept in Diabetic Retinopathy.
    Sachdeva MM
    Curr Diab Rep; 2021 Dec; 21(12):65. PubMed ID: 34902066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodegeneration in diabetic retina and its potential drug targets.
    Ola MS; Alhomida AS
    Curr Neuropharmacol; 2014 Jul; 12(4):380-6. PubMed ID: 25342945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications.
    Moran EP; Wang Z; Chen J; Sapieha P; Smith LE; Ma JX
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H738-49. PubMed ID: 27473938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets.
    Nian S; Lo ACY; Mi Y; Ren K; Yang D
    Eye Vis (Lond); 2021 May; 8(1):15. PubMed ID: 33931128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The state of ocular neurosensory apparatus in diabetes mellitus].
    Sdobnikova SV; Kulybysheva VS; Sidamonidze AL
    Vestn Oftalmol; 2018; 134(5. Vyp. 2):263-269. PubMed ID: 30499527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic Retinopathy: The Role of Mitochondria in the Neural Retina and Microvascular Disease.
    Miller DJ; Cascio MA; Rosca MG
    Antioxidants (Basel); 2020 Sep; 9(10):. PubMed ID: 32977483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of Glut1 in the Neural Retina But Not the RPE Alleviates Polyol Accumulation and Normalizes Early Characteristics of Diabetic Retinopathy.
    Holoman NC; Aiello JJ; Trobenter TD; Tarchick MJ; Kozlowski MR; Makowski ER; De Vivo DC; Singh C; Sears JE; Samuels IS
    J Neurosci; 2021 Apr; 41(14):3275-3299. PubMed ID: 33622781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SGLT2 Inhibitor-Induced Low-Grade Ketonemia Ameliorates Retinal Hypoxia in Diabetic Retinopathy-A Novel Hypothesis.
    Mudaliar S; Hupfeld C; Chao DL
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1235-1244. PubMed ID: 33512450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinational Approaches Targeting Neurodegeneration, Oxidative Stress, and Inflammation in the Treatment of Diabetic Retinopathy.
    Chalke SD; Kale PP
    Curr Drug Targets; 2021; 22(16):1810-1824. PubMed ID: 33745432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Inhibition of Spermine Oxidase Reduces Neurodegeneration and Improves Retinal Function in Diabetic Mice.
    Liu F; Saul AB; Pichavaram P; Xu Z; Rudraraju M; Somanath PR; Smith SB; Caldwell RB; Narayanan SP
    J Clin Med; 2020 Jan; 9(2):. PubMed ID: 31991839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets.
    Chakravarthy H; Devanathan V
    J Mol Neurosci; 2018 Nov; 66(3):445-461. PubMed ID: 30293228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.
    Narayanan SP; Shosha E; D Palani C
    Pharmacol Res; 2019 Sep; 147():104299. PubMed ID: 31207342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional changes in the neural retina occur in the absence of mitochondrial dysfunction in a rodent model of diabetic retinopathy.
    Masser DR; Otalora L; Clark NW; Kinter MT; Elliott MH; Freeman WM
    J Neurochem; 2017 Dec; 143(5):595-608. PubMed ID: 28902411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinflammatory cytokines trigger biochemical and neurochemical changes in mouse retinal explants exposed to hyperglycemic conditions.
    Shivashankar G; Lim JC; Acosta ML
    Mol Vis; 2020; 26():277-290. PubMed ID: 32300272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of diabetic retinopathy through neuropeptide Y-mediated enhancement of neurovascular microenvironment.
    Ou K; Copland DA; Theodoropoulou S; Mertsch S; Li Y; Liu J; Schrader S; Liu L; Dick AD
    J Cell Mol Med; 2020 Apr; 24(7):3958-3970. PubMed ID: 32141716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships Between Neurodegeneration and Vascular Damage in Diabetic Retinopathy.
    Rossino MG; Dal Monte M; Casini G
    Front Neurosci; 2019; 13():1172. PubMed ID: 31787868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.
    Wan TT; Li XF; Sun YM; Li YB; Su Y
    Biomed Pharmacother; 2015 Aug; 74():145-7. PubMed ID: 26349976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.